Aytu BioPharma (NASDAQ:AYTU) reported its Q3 earnings results on Monday, May 16, 2022 at 04:02 PM.
Here's what investors need to know about the announcement.
Earnings
Aytu BioPharma beat estimated earnings by 34.15%, reporting an EPS of $-0.27 versus an estimate of $-0.41.
Revenue was up $10.72 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14 which was followed by a 7.26% increase in the share price the next day.
Here's a look at Aytu BioPharma's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.58 | -0.49 | -0.49 | -0.31 |
| EPS Actual | -0.44 | -0.33 | -0.81 | -0.43 |
| Revenue Estimate | 27.20M | 22.10M | 20.90M | 14.06M |
| Revenue Actual | 23.12M | 21.90M | 23.48M | 13.48M |
To track all earnings releases for Aytu BioPharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
